Document is current
Any future updates will be listed below
-
Authors
Tomasik, Bartłomiej
Jąkalski, Marcin
Bieńkowski, Michał
Teodorczyk, Jacek
Sobocki, Bartosz Kamil
Stawiski, Konrad
Burzynski, Jacek
Romanowicz, Grzegorz
Dziadziuszko, Rafał
Cytawa, Wojciech
Mieczkowski, Jakub https://orcid.org/0000-0002-2091-012X
- License Information
-
More Information
Article History
Received: 5 November 2025
Accepted: 10 March 2026
First Online: 18 March 2026
Declarations
:
: BT - lecture fees from MSD and Pfizer and honoraria from Roche and Amgen. RD - Advisory/consultancy fees: Roche, Foundation Medicine, Pfizer, AstraZeneca, Novartis, Merck Sharp & Dohme, Takeda, GlaxoSmithKline. Honoraria: Roche, AstraZeneca, Amgen. Participation in Data Safety Monitoring Boards/advisory boards: Roche, AstraZeneca, Amgen, Pfizer, Merck Sharp & Dohme. Received drug sample from Novartis, Pfizer. Other Authors declare no conflict of interest.
